Globus Medical Inc’s recent filing unveils that its Director RHOADS ANN D unloaded Company’s shares for reported $0.59 million on Feb 28 ’25. In the deal valued at $78.68 per share,7,500 shares were sold. As a result of this transaction, RHOADS ANN D now holds 35,384 shares worth roughly $2.11 million.
Then, RHOADS ANN D bought 7,500 shares, generating $590,000 in total proceeds.
Before that, Pfeil Keith W sold 14,167 shares. Globus Medical Inc shares valued at $1,250,770 were divested by the COO, CFO at a price of $88.29 per share. As a result of the transaction, Pfeil Keith W now holds 0 shares, worth roughly $0.0.
BTIG Research downgraded its Globus Medical Inc [GMED] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early January from “an Underperform” to “a Neutral”. Morgan Stanley also remained covering GMED and has increased its forecast on December 02, 2024 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Wells Fargo revised its rating on August 07, 2024. It rated GMED as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of GMED
On Tuesday, Globus Medical Inc [NYSE:GMED] saw its stock jump 1.26% to $59.70. Over the last five days, the stock has gained 0.18%. Globus Medical Inc shares have fallen nearly -27.82% since the year began. Nevertheless, the stocks have fallen -10.35% over the past one year. SMA at 50 days reached $67.76, while 200 days put it at $76.01.
Levels Of Support And Resistance For GMED Stock
The Relative Strength Index (RSI) on the 14-day chart is 39.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 40.85%. Stochastics %K at 51.06% indicates the stock is a holding.
